AT
IDXX icon

Arlington Trust’s Idexx Laboratories IDXX Stock Holding History

Arlington Trust’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.6K Buy
60
+19
+46% +$10.7K ﹤0.01% 334
2026
Q1 		$23K Buy
41
+28
+215% +$18K ﹤0.01% 318
2025
Q4 		$8.79K Buy
+13
New +$8.85K ﹤0.01% 323
2024
Q1 		– Sell
-10
Closed -$5.55K – 680
2023
Q4 		$5.55K Sell
10
-5
-33% -$2.35K ﹤0.01% 462
2023
Q3 		$6.56K Buy
+15
New +$7.48K ﹤0.01% 251

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Arlington Trust's IDXX Position: Q2 2026 in Review

Arlington Trust increased its Idexx Laboratories (IDXX) stake by 46% in Q2 2026, buying an estimated $10.7K and bringing the position to 60 shares worth $31.6K. The position accounts for ﹤0.01% of the portfolio, ranked #334.

Arlington Trust first reported a position in IDXX in Q3 2023 and has held it in 5 quarters since. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Arlington Trust held 60 shares of Idexx Laboratories worth $31.6K as of Q2 2026.
  • Arlington Trust bought 19 Idexx Laboratories shares in Q2 2026, an estimated $10.7K.
  • Idexx Laboratories made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #334 holding.
  • Arlington Trust first reported a position in Idexx Laboratories in Q3 2023 and has held it in 5 quarters since.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.